No. of residents, 15–49 y | Proportion of survey population reporting syndrome in past year, 15–49 y | No. of residents reporting syndrome in past year, 15–49 y | Proportion of survey population who sought treatment at clinics, % | No. of residents seeking treatment at clinics | Syndrome aetiology | Proportion of clinic patients with aetiology | Proportion of clinic patients with curable aetiology | No. of symptomatic curable STIs in residents | No. of symptomatic curable STIs seen at clinics | Correct treatment, %* | Proportion cured, % | No. of symptomatic curable episodes due to this aetiology, cured, % | |||
Syndrome | Gender | a | b | c = a*b | d | e = c*d | f | g | h = c*g | i = e*g | j | k | l = i*j*k | m = l/h | |
GDS | M | 12 250 | 6.8% | 837.8 | 55.9 | 469 | NG | 0.59 | 0.59 | 498.1 | 278.7 | 27.4 | 100 | 76.4 | 15.2 (10.2, 21.2) |
CT | 0.07 | 0.07 | 56.6 | 31.7 | 27.4 | 83 | 7.2 | 12.3 (7.8, 17.9) | |||||||
Other† | 0.37 | ||||||||||||||
F | 16 174 | 14.9% | 2417.6 | 57.1 | 1380 | NG | 0.12 | 0.12 | 300.4 | 171.6 | 27.4 | 100 | 47.0 | 15.5 (10.6, 21.2) | |
CT | 0.11 | 0.11 | 255.0 | 145.6 | 27.4 | 87 | 34.7 | 13.4 (9.0, 18.5) | |||||||
TV | 0.29 | 0.29 | 709.2 | 404.9 | 27.4 | 87 | 96.5 | 13.6 (9.3, 18.6) | |||||||
Other† | 0.94 | ||||||||||||||
All curable GDS | 14.3 (9.8, 19.5) | ||||||||||||||
GUD | M | 12 250 | 4.3% | 526.6 | 53.2 | 280 | TP | 0.16 | 0.16 | 86.6 | 46.0 | 27.4 | 89 | 11.2 | 12.5 (7.6, 18.9) |
HD | 0.11 | 0.11 | 57.7 | 30.7 | 27.4 | 93 | 7.8 | 13.1 (8.1, 19.6) | |||||||
CT (LGV) | 0.08 | 0.08 | 44.5 | 23.7 | 27.4 | 93 | 6.0 | 13.0 (8.0, 19.6) | |||||||
HSV-2 | 0.48 | ||||||||||||||
Other† | 0.26 | ||||||||||||||
F | 16 174 | 9.8% | 1591.8 | 36.3 | 577 | TP | 0.09 | 0.09 | 138.9 | 50.4 | 27.4 | 89 | 12.3 | 8.6 (5.6, 12.4) | |
HD | 0.06 | 0.06 | 96.1 | 34.9 | 27.4 | 93 | 8.9 | 9.0 (5.9, 12.8) | |||||||
CT (LGV) | 0.17 | 0.17 | 277.8 | 100.7 | 27.4 | 93 | 25.7 | 9.0 (5.9, 12.8) | |||||||
HSV-2 | 0.50 | ||||||||||||||
Other† | 0.28 | ||||||||||||||
All curable GUD | 9.9 (6.6, 14.0) | ||||||||||||||
Overall | 2521.0 | 1318.9 | 13.1 (8.9, 17.8) |
*Median (and 95% CI if applicable) calculated using Monte-Carlo sampling, see methods; †included other known and unknown aetiologies.
CT, Chlamydia trachomatis; F, female; GDS, genital discharge syndrome; GUD, genital ulcer disease; HD, Haemophilus ducreyi; HSV-2, herpes simplex virus type 2; LGV, Lympho-granuloma venereum; M, male; NG, Neisseria gonorrhoeae; TP, Treponema pallidum; TV, Trichomonas vaginalis; y, years.